Precision BioSciences, Inc. (DTIL)
Develops gene-editing treatments to fix genetic diseases by inserting, removing, or repairing faulty DNA.
$7.11-0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+53.9%
The outlook
Precision BioSciences trades at $7.11, near the midpoint of its 52-week range with mixed near-term momentum. Analyst coverage shows an average price target roughly 3x the current price, reflecting substantial optimism, while the overall sentiment leans bullish.
What’s behind the score
Price trendMixed vs its moving averages
52-week range59% of the way from its 52-week low to high
Price targetAvg target +316% vs current price
Analyst price target
~12-month · 5 analysts$29.60average target+316.3% vs now
Now $7.11
Low $19.00High $60.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$183.5M
52-wk high
$9.62
52-wk low
$3.53
50-day avg
$7.36
200-day avg
$6.00
Trailing P/E
—